ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.71
-0.56%
US Tech 100
18,307.16
0.41%
S&P 500
5,307.01
-0.27%
US Dollar vs CAD
1.36832
-0.06%
Bitcoin
69,370.35
0.39%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Horizon Therapeutics Public Limited Company (HZNP)

  7. Horizon Therapeutics Public Limited Company (HZNP) News

HZNP

Horizon Therapeutics Pub... (HZNP)

Horizon Therapeutics Public Limited Company
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HZNP
DateTimeSourceHeadlineSymbolCompany
10/16/20233:44PMEdgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/09/20236:33AMIH Market NewsMonday’s Wall Street Highlights: Exxon Mobil, Bristol-Myers, Disney, Lockheed Martin, and moreNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20235:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20235:17PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20235:08PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20235:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20235:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20234:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20234:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20234:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20233:30PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20233:28PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20233:26PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20233:24PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20233:22PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20233:20PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20233:18PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20233:16PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20233:13PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20233:11PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20233:08PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/06/20237:30AMBusiness WireRule 17(e) Announcement - Horizon Therapeutics plcNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/05/20236:40AMBusiness WireRule 17(d) Announcement – Horizon Therapeutics plcNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/05/20236:32AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/03/202310:15AMBusiness WireRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)NASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/03/202310:06AMBusiness WireRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)NASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/02/202310:39AMBusiness WireRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)NASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/02/202310:24AMBusiness WireRule 8.1 Dealing Disclosure (Horizon Therapeutics plc)NASDAQ:HZNPHorizon Therapeutics Public Limited Company
10/02/20237:00AMBusiness WireHorizon Therapeutics plc Announces New UPLIZNA® (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS 2023NASDAQ:HZNPHorizon Therapeutics Public Limited Company
 Showing the most relevant articles for your search:NASDAQ:HZNP

Your Recent History

NASDAQ
NVDA
NVIDIA
USOTC
RDGL
Vivos (QB)
USOTC
ENZC
Enzolytics (PK)
USOTC
CBIA
Canopus Biopharma (PK)
USOTC
UBQU
Ubiquitech Software (PK)
USOTC
DPLS
DarkPulse (PK)
AMEX
SPY
SPDR S&P 500
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
RVNC
Revance Therapeutics
USOTC
SONGD
Music Licensing (PK)
USOTC
GNCP
GNCC Capital (CE)
USOTC
BLEG
Branded Legacy (PK)
USOTC
AXXA
Exxe (PK)
NASDAQ
FCEL
FuelCell Energy
NASDAQ
LWLG
Lightwave Logic
NASDAQ
AVXL
Anavex Life Sciences
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved